The co-upregulation of this axis is associated with lower survival in stomach cancer (genomically stable GI.GS subtype) and with higher survival in pancreatic cancer (GL subtype), similarly to CXCR2-CXCL3. This evidence concerns the gene CXCR2 and gastric cancer.